BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33300159)

  • 1. Identification of SRSF10 as a regulator of SMN2 ISS-N1.
    Frederiksen SB; Holm LL; Larsen MR; Doktor TK; Andersen HS; Hastings ML; Hua Y; Krainer AR; Andresen BS
    Hum Mutat; 2021 Mar; 42(3):246-260. PubMed ID: 33300159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron.
    Singh NK; Singh NN; Androphy EJ; Singh RN
    Mol Cell Biol; 2006 Feb; 26(4):1333-46. PubMed ID: 16449646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes.
    Singh RN; Singh NN
    Adv Neurobiol; 2018; 20():31-61. PubMed ID: 29916015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving concepts on human SMN pre-mRNA splicing.
    Singh RN
    RNA Biol; 2007; 4(1):7-10. PubMed ID: 17592254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.
    Cartegni L; Hastings ML; Calarco JA; de Stanchina E; Krainer AR
    Am J Hum Genet; 2006 Jan; 78(1):63-77. PubMed ID: 16385450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions.
    Singh NN; Lee BM; Singh RN
    Ann N Y Acad Sci; 2015 Apr; 1341():176-87. PubMed ID: 25727246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual masking of specific negative splicing regulatory elements resulted in maximal exon 7 inclusion of SMN2 gene.
    Pao PW; Wee KB; Yee WC; Pramono ZA
    Mol Ther; 2014 Apr; 22(4):854-61. PubMed ID: 24317636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7.
    Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H
    Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Concentration of an ISS-N1-Targeting Antisense Oligonucleotide Causes Massive Perturbation of the Transcriptome.
    Ottesen EW; Luo D; Singh NN; Singh RN
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
    Kashima T; Rao N; David CJ; Manley JL
    Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes.
    Singh NN; Seo J; Rahn SJ; Singh RN
    PLoS One; 2012; 7(11):e49595. PubMed ID: 23185376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Securinine enhances SMN2 exon 7 inclusion in spinal muscular atrophy cells.
    Chen YC; Chang JG; Liu TY; Jong YJ; Cheng WL; Yuo CY
    Biomed Pharmacother; 2017 Apr; 88():708-714. PubMed ID: 28152480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed
    Wijaya YOS; Niba ETE; Nishio H; Okamoto K; Awano H; Saito T; Takeshima Y; Shinohara M
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy.
    Pedrotti S; Bielli P; Paronetto MP; Ciccosanti F; Fimia GM; Stamm S; Manley JL; Sette C
    EMBO J; 2010 Apr; 29(7):1235-47. PubMed ID: 20186123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.
    Hofmann Y; Wirth B
    Hum Mol Genet; 2002 Aug; 11(17):2037-49. PubMed ID: 12165565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nusinersen in the Treatment of Spinal Muscular Atrophy.
    Goodkey K; Aslesh T; Maruyama R; Yokota T
    Methods Mol Biol; 2018; 1828():69-76. PubMed ID: 30171535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice.
    Hua Y; Vickers TA; Okunola HL; Bennett CF; Krainer AR
    Am J Hum Genet; 2008 Apr; 82(4):834-48. PubMed ID: 18371932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment with the histone deacetylase inhibitor LBH589 and a splice-switch antisense oligonucleotide enhances SMN2 splicing and SMN expression in Spinal Muscular Atrophy cells.
    Pagliarini V; Guerra M; Di Rosa V; Compagnucci C; Sette C
    J Neurochem; 2020 Apr; 153(2):264-275. PubMed ID: 31811660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of
    Toosaranont J; Ruschadaariyachat S; Mujchariyakul W; Arora JK; Charoensawan V; Suktitipat B; Palmer TN; Fletcher S; Wilton SD; Mitrpant C
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional RNAs targeting the intronic splicing silencer N1 increase SMN levels and reduce disease severity in an animal model of spinal muscular atrophy.
    Osman EY; Yen PF; Lorson CL
    Mol Ther; 2012 Jan; 20(1):119-26. PubMed ID: 22031236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.